Tom 10, Nr 3 (2017)
Sprawozdanie z konferencji / Sprawozdanie
Opublikowany online: 2017-10-25
Wyświetlenia strony
345
Wyświetlenia/pobrania artykułu
957
Wybrane zagadnienia dotyczące inaktywacji biologicznych czynników chorobotwórczych w składnikach krwi w świetle doniesień prezentowanych na 27. regionalnym Kongresie ISBT w Kopenhadze (17–21 czerwca 2017 r.)
Journal of Transfusion Medicine 2017;10(3):107-111.
Streszczenie
xx
Słowa kluczowe: Wybrane zagadnienia
Referencje
- Dimberg LY, Doane S, Yonemura S, et al. Quallity of red blood cells derived from whole blood treated with UV light and riboflavin. Vox Sanguinis. 2017; 112(Suppl.1): P–248.
- Dimberg LY, Doane S, Hovenga N, et al. and Marschner S: Quality of whole blood treated with UV light and riboflavin after 24 H in room temperature. Vox Sanguinis. 2017; 112(Suppl.1): P–249.
- Taha M, Culibrk B, Schubert P, et al. and Ramirez-Arcos S: Inactivation of biofilm –derived staphylococcus epidermidis in platelet concentrates with riboflavin and staphylococcus epidermidis in platelet concentrates with riboflavin and ultraviolet light treatment. Vox Sanguinis. 2017; 112(Suppl.1): P–252.
- Yonemura S, Doane S, Gosney J, et al. Assessment of cell quality following riboflavin and ultraviolet light treatment of whole blood in citrate-phosphate-dextrose-adenine anticoagulant. Vox Sanguinis. 2017; 112(Suppl.1): P–264.
- Yonemura S, Doane S, Gilmour D, et al. Assessment of pathogen reduction capacity following riboflavin and ultraviolet light treatment of whole blood in citrate-phosphate-dextrose-adenine anticoagulant. Vox Sanguinis. 2017; 112(Suppl.1): P–265.
- Lachert E, Kubis J, Antoniewicz-Papis J, Rosiek A, Mikolowska A, and Letowska M. Pathogen inactivations systems in Polish Blood Transfusion Centers in 2012–2015. Vox Sanguinis 2017, 112, (Suppl.1), P-268.
- Jimenez-Marco T, Garcia-Recio M, Bautista-Gili A, et al. Riboflavin and UV light treated platelets ensure an adequate transfusion dose, similar to untreated platelets. Vox Sanguinis. 2017; 112(Suppl.1): P–271.
- Gravemann U, Handke W, Sumian C, et al. Influence of the temperature on the quality and virus inactivation capacity of methylene-blue treated plasma using the Theraflex MB-plasma System. Vox Sanguinis. 2017; 112(Suppl.1): P–257.
- Gravemann SU, Tolksdorf F, Handke W. Culler and Seltsam A: Effectiveness of the THERAFLEX UV-PLATELETS technology against clinically relevant transfusion – transmited bacteria strains. Vox Sanguinis. 2017; 112(Suppl.1): P–251.
- Brixner V, Dombos S, Weber I, et al. In vitro assessment of untreated, UVC-treated and gamma-irradiated plasma reduced platelet concentrates prepared from thrombapheresis under routine conditions. Vox Sanguinis. 2017; 112(Suppl.1): P–253.
- Marks DC, Fryk J, Hobson-Peters J, et al. Zika virus infectivity is reduced following treatment with the Theraflex UVC-Platelets and Theraflex MB-Plasma Systems. Vox Sanguinis. 2017; 112(Suppl.1): P–258.
